Form 8-K - Current report:
SEC Accession No. 0001104659-23-003827
Filing Date
2023-01-13
Accepted
2023-01-13 16:16:17
Documents
12
Period of Report
2023-01-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm233317d1_8k.htm   iXBRL 8-K 29233
  Complete submission text file 0001104659-23-003827.txt   203661

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20230108.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20230108_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20230108_pre.xml EX-101.PRE 22601
6 EXTRACTED XBRL INSTANCE DOCUMENT tm233317d1_8k_htm.xml XML 3601
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 23528956
SIC: 2834 Pharmaceutical Preparations